Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adware, anktiva, argued, AstraZeneca, attack, authentication, barry, Bio, bleomycin, broadening, cancelable, CCPA, CG, cGCP, cGLP, chance, cloud, cohort, Colorado, contrary, CPRA, credential, CRF, criterion, cubic, curb, customarily, DCF, de, deceptive, deletion, disciplined, downtime, doxycycline, EEA, encryption, Endo, enGene, ethanol, EU, evolution, exemplify, expert, explicit, explicitly, exploitable, extortion, extra, FerGene, flannelly, gamma, GDPR, GDRP, geopolitical, Geral, hallmark, huang, IFN, ImmunityBio, Inline, instiladrin, jane, Keytruda, Kingdom, leasehold, legitimate, Lei, LGPD, Linkbase, macroeconomic, malfunction, malware, marker, MFN, mobile, multinational, noncurrent, ODD, offline, Olivo, omicron, online, opt, OTAT, ourself, Oxley, payroll, Pfizer, phishing, PK, plc, ransomware, redeployment, refine, reinstituted, renewal, repurchase, rescinded, Rescue, residency, retention, Roche, sasanlimab, Schema, screen, Seagen, Sebastian, Sesen, similarly, Squibb, stuffing, Subtopic, sulfate, supervisory, tangible, Taxonomy, tenant, terminology, tetradecyl, theft, tie, Tokyo, topline, truthful, UK, undiscounted, unemployment, Valstar, variant, verification, vicineum, Virginia, weaker, weekly, weigh, XBRL
Removed:
arm, attribution, billion, Blueprint, calculating, cautionary, circuit, commitment, comparing, compute, Cowen, deposit, district, exercisable, exhaustive, fourth, inappropriate, input, intensity, judge, lessee, margin, month, nonexclusive, partnership, periodically, pocket, practical, proposal, recognizing, remeasured, reproduce, revision, seeking, step, trust, utilize, vulnerable
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 List of Subsidiaries
- 23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
- 23.2 Consent of Marcum LLP, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- Download Excel data file
- View Excel data file
Related press release
TARA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Forms S-8 Nos. 333-254124, 333-237497, 333-235918, 333-229123, 333-222415 and 333-200587) pertaining to the Amended and Restated 2014 Equity Incentive Plan, as amended and 2014 Employee Stock Purchase Plan of Protara Therapeutics, Inc., and |
(2) | Registration Statement (Form S-3 No. 333-251224) of Protara Therapeutics, Inc.; |
of our report dated March 9, 2022, with respect to the consolidated financial statements of Protara Therapeutics, Inc. included in this Annual Report (Form 10-K) of Protara Therapeutics, Inc. for the year ended December 31, 2021.
/s/ Ernst & Young LLP | |
New York, New York | |
March 9, 2022 |